Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer

被引：0
|
作者：
Akerlund, Emma [1 ]
Gudoityte, Greta [1 ]
Lamodiere, Elisabeth Moussaud [1 ]
Carlson, Joseph [2 ]
Wallin, Emelie [2 ]
Fernebro, Josefin [2 ]
Kallioniemi, Olli [1 ]
Ostling, Paivi [1 ]
Joneborg, Ulrika [2 ]
Seashore-Ludlow, Brinton [1 ]
机构：
[1] Karolinska Inst, Sci Life Lab, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1890
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Architectural organization and molecular profiling of 3D cancer heterospheroids and their application in drug testing
    Nielsen, Boye Schnack
    Madsen, Natasha Helleberg
    Larsen, Jesper
    Skandorff, Isabella
    Gad, Monika
    Holmstrom, Kim
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] PREDICTING RESPONSE TO CHEMOTHERAPY IN HIGH GRADE GLIOMAS USING EX VIVO 3D CELL CULTURE FUNCTIONAL PRECISION ONCOLOGY PLATFORM - A MULTI-INSTITUTIONAL EXPERIENCE
    Mrugala, Maciej
    Hrachova, Maya
    Sherman, Wendy
    Ensign, Shannon Fortin
    Blomquist, Mylan
    Porter, Alyx
    Thompson, Tracy
    Greene, Denia
    Anastasiadis, Panos
    Vasmatzis, George
    Lin, Wan-Hsin
    Dunn, Ian
    Quinones-Hinojosa, Alfredo
    Zimmerman, Richard
    Swanson, Kristin
    Bendok, Bernard
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [43] DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM
    Peterziel, Heike
    Jamaladdin, Nora
    El Harouni, Dina
    Gerloff, Xenia F.
    Herter, Sonja
    Fiesel, Petra
    Berker, Yannick
    Blattner-Johnson, Mirjam
    Schramm, Kathrin
    Jones, Barbara C.
    Reuss, David
    Turunen, Laura
    Friedenauer, Aileen
    Holland-Letz, Tim
    Sill, Martin
    Weiser, Lena
    Previti, Christopher
    Ubramanian, Gnanaprakash Balas
    Gerber, Nicolas U.
    Gojo, Johannes
    Hutter, Caroline
    Ora, Ingrid
    Lohi, Olli
    Kattamis, Antonis
    De Wilde, Bram
    Termann, Frank Wes
    Tippelt, Stephan
    Graf, Norbert
    Nathrath, Michaela
    Sparber-Sauer, Monika
    Sehested, Astrid
    Kramm, Christof M.
    Dirksen, Uta
    Kallioniemi, Olli
    Pfister, Stefan M.
    Van Tilburg, Cornelis M.
    Jones, David T. W.
    Saarela, Jani
    Pietiainen, Vilja
    Jager, Natalie
    Schlesner, Matthias
    Kopp-Schneider, Annette
    Oppermann, Sina
    Milde, Till
    Witt, Olaf
    Oehme, Ina
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [44] Precision cancer medicine based on 3D drug profiling of patient-derived cancer cell spheroid models
    Mikkonen, Piia
    Turunen, Laura
    Paasonen, Lauri
    Potdar, Swapnil
    Paavolainen, Lassi
    Murumagi, Astrid
    Kallioniemi, Olli
    Pietiainen, Vilja M.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [45] Imaging of prostate cancer: a platform for 3D co-registration of in-vivo MRI ex-vivo MRI and pathology
    Orczyk, Clement
    Mikheev, Artem
    Rosenkrantz, Andrew
    Melamed, Jonathan
    Taneja, Samir S.
    Rusinek, Henry
    [J]. MEDICAL IMAGING 2012: IMAGE-GUIDED PROCEDURES, ROBOTIC INTERVENTIONS, AND MODELING, 2012, 8316
  • [46] Ex vivo 3d drug response profiling of primary human ovarian cancer differentiates treatment-naive and relapsed patients and molecular subtypes
    Desrochers, Tessa
    Shuford, Stephen
    Mattingly, Christina
    Holmes, Lillia
    Gevaert, Matt
    Elder, Jeff
    Orr, David
    Corless, Christopher
    Puls, Larry
    Crosswell, Hal E.
    [J]. CANCER RESEARCH, 2015, 75
  • [47] Development of perfusion-based micro 3-D cell culture platform and its application for high throughput drug testing
    Wu, Min-Hsien
    Huang, Song-Bin
    Cui, Zhanfeng
    Cui, Zheng
    Lee, Gwo-Bin
    [J]. SENSORS AND ACTUATORS B-CHEMICAL, 2008, 129 (01): : 231 - 240
  • [48] Ex vivo 3D drug response profiling of XPDX-derived tumor cells for acceleration of preclinical drug development
    Carlson, Aaron L.
    Elrod, Ashley K.
    Williams, Natalie A.
    Moriarty, Alyssa D.
    Wick, Michael J.
    DesRochers, Teresa M.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [49] 3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients
    Cabeza, M.
    Papaccio, F.
    Gutierrez Bravo, M. F.
    Gambardella, V.
    Alfaro-Cervello, C.
    Martinez-Ciarpaglini, C.
    Garzon-Lloria, Z.
    Rentero-Garrido, P.
    Zuniga-Trejos, S.
    Seda-Garcia, E.
    Gimeno-Valiente, F.
    Pena, A.
    Barrios, M.
    Tarazona, N.
    Roda, D.
    Cervantes, A.
    Fleitas, T.
    Castillo, J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S919 - S919
  • [50] A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine
    Plummer, Simon
    Wallace, Stephanie
    Ball, Graeme
    Lloyd, Roslyn
    Schiapparelli, Paula
    Quinones-Hinojosa, Alfredo
    Hartung, Thomas
    Pamies, David
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
12345